Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by La Bella, V.
Right arrow Articles by Appel, S. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by La Bella, V.
Right arrow Articles by Appel, S. H.
NEUROLOGY 1997;48:1270-1272
© 1997 American Academy of Neurology

Increased CSF glutamate following injection of ALS immunoglobulins

Vincenzo La Bella, MD, PhD, J. Clay Goodman, MD, PhD and Stanley H. Appel, MD

From the Departments of Neurology (Drs. La Bella and Appel) and Pathology (Dr. Goodman), Baylor College of Medicine, Houston, TX.

To reconcile the autoimmune and excitotoxic hypotheses regarding the etiology of amyotrophic lateral sclerosis (ALS), we injected rats intraperitoneally with ALS immunoglobulins and monitored CSF glutamate, aspartate, glutamine, and glutathione. CSF glutamate was significantly increased at 24 and 72 hours compared with both basal levels and disease control injected rats. CSF aspartate was increased at 72 hours. Glutamine and glutathione were unchanged. These data suggest that ALS immunoglobulins may enhance CSF glutamate and aspartate levels and contribute to motoneuron injury.




This article has been cited by other articles:


Home page
BrainHome page
T. M. Tikka, N. E. Vartiainen, G. Goldsteins, S. S. Oja, P. M. Andersen, S. L. Marklund, and J. Koistinaho
Minocycline prevents neurotoxicity induced by cerebrospinal fluid from patients with motor neurone disease
Brain, April 1, 2002; 125(4): 722 - 731.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by AAN Enterprises, Inc.